Aller au contenu
Santé cardiovasculaireÉtude de cohorte4 min read

Heart scarring on MRI linked to arrhythmia in 106 veteran male endurance athletes

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Ventricular Arrhythmia and Cardiac Fibrosis in Endurance Experienced Athletes (VENTOUX). · Circulation. Cardiovascular imaging · 2025 · Article original ↗

À retenir

Among 106 asymptomatic male cyclists and triathletes aged 50 or older, 50 (47.2%) had myocardial fibrosis on MRI, and fibrosis was linked to a higher hazard of ventricular arrhythmia on a loop recorder (HR 4.7, 95% CI 1.8-12.8) over a median 720 days. Few men, short follow-up and a wide interval make this a signal, not a risk calculator.

Study design

Étude de cohorte

Reading basis

Published abstract

Reading focus

Association & confounding

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Sudden cardiac death from a primary rhythm disorder is a leading cause of death in athletes, mostly older men, yet the meaning of fibrosis in the heart muscle of endurance athletes without symptoms is unknown. The authors tested whether fibrosis seen on cardiac MRI predicts ventricular arrhythmia detected by a long-term implanted loop recorder.

Population et méthode

Prospective observational cohort study (VENTOUX) of 106 asymptomatic male competitive cyclists and triathletes aged 50 or older who had exercised at least 10 hours a week for at least 15 years and had no preexisting cardiovascular disease. Participants had a clinical assessment, stress-perfusion late gadolinium enhancement cardiovascular magnetic resonance (CMR), exercise testing and implantation of a loop recorder to detect ventricular arrhythmia. The primary end point was incident ventricular arrhythmia during follow-up, reported as hazard ratios. The abstract does not describe how fibrosis was graded or how many centers took part.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    On MRI, 50 of 106 athletes (47.2%) had focal myocardial fibrosis, all with a nonischemic distribution, mostly in the basal inferolateral segment of the left ventricle.
  2. 2
    During a median follow-up of 720 days, 23 of 106 athletes (21.7%) had at least 1 ventricular arrhythmic episode: 3 (2.8%) had sustained ventricular tachycardia and 20 (18.9%) had nonsustained ventricular tachycardia.
  3. 3
    Myocardial fibrosis was associated with a higher risk of ventricular arrhythmia (HR 4.7; 95% CI 1.8-12.8; P=0.002), and so was a greater indexed left ventricular end-diastolic volume (HR 1.4; 95% CI 1.1-1.9; P=0.02).
  4. 4
    Right ventricular insertion point late gadolinium enhancement showed no clear association (HR 1.7; 95% CI 0.6-5.1; P=0.32). Fibrosis stayed predictive after adjusting for left ventricular volume (HR 4.7; 95% CI 1.7-12.7; P=0.002).

Limites et incertitude

  1. 1
    Only 106 men, all aged 50 or older and highly trained cyclists or triathletes, with a median follow-up of 720 days; the confidence interval around the fibrosis estimate (1.8 to 12.8) is wide.
  2. 2
    There is no comparison group of non-athletes or less active men, so the study cannot say whether endurance exercise causes the fibrosis.
  3. 3
    Outcomes were arrhythmias detected by a loop recorder, mostly nonsustained; the abstract reports no cardiac arrest, sudden death or other clinical events. The authors say it is not known whether fibrosis itself is arrhythmogenic or a marker of an underlying cardiomyopathic process.
  4. 4
    The abstract does not report how accurately MRI fibrosis would pick out athletes who will develop arrhythmia. This reading is based on the abstract only.

Mise en perspective

For veteran male endurance athletes, this study suggests that fibrosis in the heart muscle on MRI may go with a higher chance of ventricular rhythm problems, but it cannot say whether the fibrosis or the training causes them. It does not show that endurance exercise is harmful, and decisions about training and testing belong with a clinician. Athletes with palpitations, fainting or chest pain, or who are unsure about their own risk, should ask a clinician whether cardiac testing makes sense.

Vos données

This is not something to track yourself. Fibrosis is found with cardiac MRI, and the arrhythmias in the study were picked up by an implanted loop recorder, which a watch or chest strap cannot match; heart rate, resting heart rate and VO2max estimates say nothing about scarring. If you have symptoms such as palpitations or fainting, or a watch flags an irregular rhythm, bring that record to a clinician instead of interpreting it alone.

Comprendre ce type de preuve

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Sudden cardiac death due to primary arrhythmia is a leading cause of mortality in athletes, predominantly affecting older male athletes. Myocardial fibrosis is strongly associated with arrhythmogenesis in nonischemic cardiomyopathy, but its clinical significance in asymptomatic endurance athletes is unknown. We aimed to investigate whether myocardial fibrosis on cardiovascular magnetic resonance in asymptomatic veteran male athletes was associated with incident ventricular arrhythmia on long-term implantable loop recorder.

Methods

Prospective observational cohort study involving 106 asymptomatic male competitive cyclists/triathletes (aged ≥50 years) who undertook ≥10 h/wk of exercise for ≥15 years. Exclusion criteria were any preexisting cardiovascular disease. Participants underwent clinical assessment, stress-perfusion late gadolinium enhancement-cardiovascular magnetic resonance, exercise testing, and implantable loop recorder implantation to detect ventricular arrhythmia. Athletes were followed up for the primary end point of incident ventricular arrhythmia.

Results

A total of 50/106 (47.2%) athletes had focal myocardial fibrosis (all nonischemic distribution) on cardiovascular magnetic resonance predominantly affecting the basal inferolateral left ventricular segment. During follow-up (median 720 days), 23/106 (21.7%) athletes experienced ≥1 ventricular arrhythmic episode; 3/106 (2.8%) sustained ventricular tachycardia, and 20/106 (18.9%) nonsustained ventricular tachycardia. Myocardial fibrosis (hazard ratio, 4.7 [95% CI, 1.8-12.8]; P =0.002) and greater left ventricular end-diastolic volume indexed (hazard ratio, 1.4 [95% CI, 1.1-1.9]; P =0.02) were associated with an increased risk of incident ventricular arrhythmia, but right ventricular insertion point late gadolinium enhancement was not (hazard ratio, 1.7 [95% CI 0.6-5.1]; P =0.32). Myocardial fibrosis remained predictive after adjusting for left ventricular end-diastolic volume indexed (hazard ratio, 4.7 [95% CI, 1.7-12.7]; P =0.002).

Conclusions

In male veteran endurance athletes, myocardial fibrosis was independently associated with the onset of ventricular arrhythmia, even after adjusting for left ventricular dilatation. Right ventricular insertion point late gadolinium enhancement was not associated with ventricular arrhythmia. Further studies are needed to establish whether myocardial fibrosis itself is arrhythmogenic or a marker of an underlying cardiomyopathic process.

Sources et attribution

Ventricular Arrhythmia and Cardiac Fibrosis in Endurance Experienced Athletes (VENTOUX).

Javed W, Botis I, Goh ZM, Shabi M, Brown B, Tomoaia R, Farooq M, Levelt E, Graham L, Gierula J, Kellman P, Greenwood JP, Plein S, Swoboda PP.

Circulation. Cardiovascular imaging · 2025-07-17

DOI: 10.1161/circimaging.125.018470 ↗PubMed · 40675176 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Méta-analyse observationnelle

Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people

Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.

Journal of the American Heart Association

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Five exercise types lowered resting blood pressure, isometric training the most

Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
·Essai randomisé

A salt substitute lowered stroke, major cardiovascular events and death in rural China

In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.

The New England Journal of Medicine

Explications approfondiesLire l’étude →
·Validation : étude/revue

Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation

Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.

The New England Journal of Medicine

Explications approfondiesLire l’étude →
Santé cardiovasculaire →